Smoking cessation Mental and Behavioural Disorders Mental and behavioural disorders due to use of tobacco
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Current participant inclusion criteria as of 24/06/2021: 1. Participant in the clinical lung health screening programme (aged 55 to 75 years recorded as ever smokers in their medical records) 2. Current smoker 3. Only those who express a wish to quit smoking will be included in the primary endpoint analysis Previous participant inclusion criteria: 1. Participant in the clinical lung health screening programme (aged 50 to 65 years and any history of smoking) 2. Current smoker 3. Only those who express a wish to quit smoking will be included in the primary endpoint analysis
Exclusion criteria
Exclusion criteria: Non-smokers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quit rate in those wishing to quit, based on self-report by telephone call at 3 months following the initial screening visit | — |
Secondary
| Measure | Time frame |
|---|---|
| Current secondary outcome measures as of 18/05/2022: 1. Quit rate in all screening program participants, based on self-report by telephone call at 3 months following the initial screening visit 2. Mortality at 1 year (available as part of the routine evaluation of the screening protocol) 3. Quit rate at 1 year Exploratory outcomes: 1. The impact of the smoking cessation interventions (based on self-report by telephone call at three months) in different baseline groups including: 1.1. Those with new abnormal findings found as part of screening (e.g. spirometry) 1.2. Those with or without an abnormal CT finding that requires further follow up 2. The number of individuals who are smoking and who wish to quit will also be documented to provide guidance for service development and resource requirements Previous secondary outcome measures: 1. Quit rate in all screening program participants, based on self-report by telephone call at 3 months following the initial screening visit 2. Mortality at 1 year (available as part of the routine evaluation of the screening protocol) Exploratory outcomes: 1. The impact of the smoking cessation interventions (based on self-report by telephone call at three months) in different baseline groups including: 1.1. Those with new abnormal findings found as part of screening (e.g. spirometry) 1.2. Those with or without an abnormal CT finding that requires further follow up 2. The number of individuals who are smoking and who wish to quit will also be documented to provide guidance for service development and resource requirements | — |
Countries
England, United Kingdom